| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.68B | 22.49B | 20.49B | 18.91B | 19.39B | 20.46B |
| Gross Profit | 6.43B | 7.17B | 6.25B | 5.64B | 5.46B | 5.51B |
| EBITDA | 2.45B | 3.06B | 2.37B | 2.37B | 1.84B | 1.52B |
| Net Income | 2.24B | 2.07B | 2.11B | 1.54B | 1.27B | 978.42M |
Balance Sheet | ||||||
| Total Assets | 20.99B | 21.39B | 21.53B | 19.40B | 18.73B | 17.84B |
| Cash, Cash Equivalents and Short-Term Investments | 11.35B | 11.01B | 11.15B | 9.90B | 9.20B | 9.36B |
| Total Debt | 23.07M | 9.28M | 29.97M | 60.08M | 102.12M | 153.93M |
| Total Liabilities | 6.95B | 7.53B | 7.30B | 7.15B | 8.09B | 7.71B |
| Stockholders Equity | 14.04B | 13.87B | 14.23B | 12.25B | 10.63B | 10.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.85B | 2.20B | 1.18B | 697.70M | 1.25B |
| Operating Cash Flow | 0.00 | 2.98B | 2.21B | 1.51B | 1.17B | 1.57B |
| Investing Cash Flow | 0.00 | -614.23M | -415.29M | -316.29M | -636.51M | -63.03M |
| Financing Cash Flow | 0.00 | -2.51B | -507.69M | -504.39M | -693.15M | -403.19M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥29.62B | 10.77 | ― | 4.36% | 7.11% | 20.03% | |
77 Outperform | ¥29.92B | 11.19 | ― | 2.93% | 7.86% | 28.33% | |
75 Outperform | ¥21.93B | 11.46 | ― | 3.93% | 9.72% | 1.57% | |
74 Outperform | ¥26.91B | 11.87 | ― | 2.45% | 8.50% | 2.04% | |
69 Neutral | ¥30.11B | 8.54 | ― | 2.22% | 12.35% | 56.74% | |
65 Neutral | ¥30.17B | 20.84 | 10.34% | 4.82% | -2.76% | 36.33% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |